Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Avigdor

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Clinical Nuclear Medicine|August 22, 2008
PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loadsElinor Goshen, Tima Davidson, Abraham Avigdor, et al.
AJR. American Journal of Roentgenology|March 22, 2002
Calcification in lymphoma occurring before therapy: CT features and clinical correlationSara Apter, Abraham Avigdor, Gabriela Gayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reducedAvichai Shimoni, Moshe Yeshurun, Izhar Hardan, et al.
Leukemia & Lymphoma|September 7, 2018
Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?Drorit Merkel, Shelly Soffer, Iliya Novikov, et al.
Annals of Hematology|March 11, 2023
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survivalTamer Hellou, Omri Cohen, Abraham Avigdor, et al.
European Journal of Haematology|September 21, 2022
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 yearsGabriel Heering, Maya Sasson, Dan Dominissini, et al.
The Ocular Surface|October 3, 2025
Interdisciplinary management of belantamab mafodotin-associated ocular toxicity in clinical practiceMattan Arazi, Aya Wattad, Hila Magen, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 30, 2023
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia PatientsLiron Miller, Mor Freed-Freundlich, Avichai Shimoni, et al.
British Journal of Haematology|July 25, 2003
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphomaAvichai Shimoni, Izhar Hardan, Abraham Avigdor, et al.
Cancer|February 23, 2016
Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 yearsMerav Leiba, Adi Leiba, Lital Keinan-Boker, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Clinical Nuclear Medicine|August 22, 2008
PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loadsElinor Goshen, Tima Davidson, Abraham Avigdor, et al.
AJR. American Journal of Roentgenology|March 22, 2002
Calcification in lymphoma occurring before therapy: CT features and clinical correlationSara Apter, Abraham Avigdor, Gabriela Gayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reducedAvichai Shimoni, Moshe Yeshurun, Izhar Hardan, et al.
Leukemia & Lymphoma|September 7, 2018
Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?Drorit Merkel, Shelly Soffer, Iliya Novikov, et al.
Annals of Hematology|March 11, 2023
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survivalTamer Hellou, Omri Cohen, Abraham Avigdor, et al.
European Journal of Haematology|September 21, 2022
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 yearsGabriel Heering, Maya Sasson, Dan Dominissini, et al.
The Ocular Surface|October 3, 2025
Interdisciplinary management of belantamab mafodotin-associated ocular toxicity in clinical practiceMattan Arazi, Aya Wattad, Hila Magen, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 30, 2023
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia PatientsLiron Miller, Mor Freed-Freundlich, Avichai Shimoni, et al.
British Journal of Haematology|July 25, 2003
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphomaAvichai Shimoni, Izhar Hardan, Abraham Avigdor, et al.
Cancer|February 23, 2016
Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 yearsMerav Leiba, Adi Leiba, Lital Keinan-Boker, et al.
Pageof 12